Beth Rhodes

Direttore/Membro del Consiglio presso Northern Therapeutics, Inc.

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Mike Moniz	M	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-
Éric DesRosiers	M	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-
Anatoly Langer	M	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-
Rothblatt Martine	M	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-
Leong-Poi Howard	M	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-
Mei Shirley	F	-	Northern Therapeutics, Inc. Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada.	-